Table 3 Hazard ratios for risk of mortality in gastric cancer patients receiving postoperative adjuvant chemotherapy (pac) or not according to TIL and TAM status
| Â | Â | Risk of mortality | ||
|---|---|---|---|---|
Variable | No. of patients | (TIL positive + TAM negative) vs. others | ||
Entire cohort | Â | 401 (100%) | HR (95% CI) | p value |
With PAC | 256 (63.8%) | 0.466 (0.265–0.821) | 0.008 | |
Without PAC | 145 (36.2%) | 0.543 (0.195–1.515) | 0.243 | |
Stage II/III cohort | Â | 266 (100%) | Â | Â |
With PAC | 226 (85.0%) | 0.458 (0.257–0.817) | 0.008 | |
Without PAC | 40 (15.0%) | 0.534 (0.191–1.496) | 0.233 | |